Stock Analysis
McKesson Corporation (MCK) Stock Analysis
McKesson Corporation (MCK) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
McKesson Corporation (MCK) currently has an AIQ Score of 49/100, indicating a neutral setup. Value is the strongest factor at 57/100. Quality is the weakest current factor at 32/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
MCK at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $994.58 |
| AIQ Score | 49/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Buy |
| Market Cap | $106.16B |
| P/E Ratio (TTM) | 24.16 |
| Forward P/E | — |
| EPS (quarter ended 2026-06-30) | $5.17 |
| Revenue (quarter ended 2026-06-30) | $105.38B |
| Dividend Yield (TTM) | 0.37% |
| Beta | 0.31 |
| Volume | 763.21K |
| 52-week range | $723.68-$1,030.27 |
| RSI 14 | 61.6 |
| 50-Day SMA | $919.07 |
| 200-Day SMA | $861.83 |
| Analyst Price Target | $990.56 |
| Next Earnings | Nov 4, 2026 |
MCKMcKesson Corporation
Healthcare / Medical - Distribution
Low Priority
In Line With Peers
Latest quote
- Momentum57
- Value57
- Quality32
- Risk resilience53
- Sentiment—
MCK Stock Analysis Summary
McKesson Corporation (MCK) currently has an AIQ Score of 49/100, indicating a neutral setup. Value is the strongest factor at 57/100. Quality is the weakest current factor at 32/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, MCK has AIQ Score of 49/100 with Value base of 57/100 and fading Quality at 32/100. Wait for component alignment before adding exposure.
Value (57/100) leads while Quality (32/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · 1.40% stock move · MCK classified in Medical - Distribution.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is MCK Bullish or Bearish Right Now?
MCK currently has a neutral overall setup. Momentum is the strongest factor at 57/100, while Quality is weakest at 32/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Price is +6.73% above its 50-day SMA.
- - Technical consensus has more buy votes than sell votes (26 vs 9).
- - Analyst target implies -0.40% downside from the latest quote.
Current Consensus
MCK's Technical Analysis Consensus is currently Buy, with 26 buy, 10 neutral, and 9 sell votes. MCK's 14-day RSI is 61.6, which places the stock in a constructive momentum range. MCK's beta is 0.31, indicating lower market sensitivity than the broad market.
What Changed in MCK?
The largest recent change in MCK is Momentum moving down by 38.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.
What Would Change the MCK Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
MCK Decision Framework
Public evidence layers, setup checks, and risk context for McKesson Corporation.
McKesson Corporation (MCK) Stock Analysis
McKesson Corporation has an AIQ Score of 49/100 in a Neutral regime. Momentum is strongest at 57/100. Beta is 0.3, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | MCK is in a Neutral AIQ regime with score 49/100. |
| Signal Conflict | The primary conflict is that momentum leads at 57/100 while quality lags at 32/100. |
| Factor Evidence | Momentum 57/100 · Value 57/100 · Quality 32/100 · Risk 53/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Momentum is the strongest factor at 57/100.
Momentum is 57/100 and RSI (14) is 61.6.
MCK is in a Neutral regime at 49/100.
Risk factor is 53/100 with beta 0.3 and annual volatility 31.14%.
Current conflict: momentum leads at 57/100 while quality lags at 32/100.
MCK Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
MCK Fundamentals
MCK valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
MCK Technical Analysis
MCK technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
MCK Stock Catalysts
Track MCK earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
MCK Dividend Analysis
MCK dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
MCK Financial Data
MCK revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
MCK Risk Analysis
MCK volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
MCK Stock News
MCK stock news, market tone, recent headlines, and catalyst context.
MCK vs Healthcare Services / Managed Care Peers
Current peer cohort: MCK · MOH · OSCR · PGNY · PHR. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| MCK Current stock | 49/100 | 57/100 | 57/100 | 53/100 | 0.65 | 31.14% | Current |
| MOH Molina Healthcare | 40/100 | 49/100 | 46/100 | 51/100 | 0.62 | 50.62% | MCK vs MOH |
| OSCR Oscar Health | 57/100 | 59/100 | 36/100 | 30/100 | 1 | 67.19% | MCK vs OSCR |
| PGNY Progyny | 59/100 | 51/100 | 65/100 | 70/100 | 0.93 | 54.37% | MCK vs PGNY |
| PHR Phreesia | 59/100 | 42/100 | 79/100 | 59/100 | -0.81 | 58.58% | MCK vs PHR |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Oct 29, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts3 recent quarterly periods are available for review.
Checked Oct 31, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching MCK
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for MCK
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
MCK Stock FAQ
What is MCK stock price today?
McKesson Corporation's current stock price is $994.58. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is MCK bullish or bearish right now?
MCK's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is MCK's market cap?
MCK's market cap is $106.16B based on the latest completed market-close snapshot from Oct 30, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is MCK's current P/E ratio?
MCK's current P/E ratio is 24.16 based on the latest completed market-close snapshot from Oct 30, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is MCK's RSI?
MCK's 14-day RSI is 61.6 based on the latest completed market-close snapshot from Oct 30, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is MCK above its 50-day and 200-day moving averages?
MCK is 6.73% from its 50-day SMA and 13.81% from its 200-day SMA based on the latest completed market-close snapshot from Oct 30, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is MCK's next earnings date?
MCK's next earnings date is currently listed as Nov 4, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does MCK pay a dividend?
MCK's dividend yield is 0.37% based on the latest completed market-close snapshot from Oct 30, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.